ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Arcellx Inc

Arcellx Inc (ACLX)

85.475
1.04
( 1.23% )
Updated: 12:55:12

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
85.475
Bid
85.40
Ask
85.51
Volume
118,531
84.68 Day's Range 86.00
30.88 52 Week Range 88.66
Market Cap
Previous Close
84.435
Open
86.00
Last Trade
5
@
85.475
Last Trade Time
12:56:58
Financial Volume
$ 10,127,896
VWAP
85.4451
Average Volume (3m)
446,997
Shares Outstanding
53,755,679
Dividend Yield
-
PE Ratio
-64.94
Earnings Per Share (EPS)
-1.32
Revenue
110.32M
Net Profit
-70.69M

About Arcellx Inc

Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Arcellx Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ACLX. The last closing price for Arcellx was $84.44. Over the last year, Arcellx shares have traded in a share price range of $ 30.88 to $ 88.66.

Arcellx currently has 53,755,679 shares outstanding. The market capitalization of Arcellx is $4.54 billion. Arcellx has a price to earnings ratio (PE ratio) of -64.94.

Arcellx (ACLX) Options Flow Summary

Overall Flow

Bullish

Net Premium

180k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

50.00%

Sweeps Ratio

0.00%

ACLX Latest News

Arcellx Provides Second Quarter 2024 Financial Results and Business Updates

-- Earned a $68M milestone payment from Kite for iMMagine-1 enrollment -- -- Submitted an abstract for the iMMagine-1 study at the 66th ASH Annual Meeting -- -- The global Phase 3 trial...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
16.7458.5672551759278.7388.6678.0575015384.90789969CS
414.23519.981751824871.2488.6664.149535577.14369136CS
1231.78559.20096852353.6988.664944699766.78127247CS
2614.45520.353421571471.0288.6647.8846198560.14022428CS
5251.575152.13864306833.988.6630.8852980355.5267004CS
15666.475349.8684210531988.666.03547846339.53511043CS
26066.475349.8684210531988.666.03547846339.53511043CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
OCTOEightco Holdings Inc
$ 3.7599
(51.00%)
93.15M
INVZWInnoviz Technologies Ltd
$ 0.18
(45.69%)
11.02k
RZLVRezolve AI Ltd
$ 6.768
(37.56%)
1.45M
SBCSBC Medical Group Holdings Incorporated
$ 9.12
(37.56%)
1.38M
ATGLAlpha Technology Group Limited
$ 1.95
(35.16%)
1.43M
VTNRVertex Energy Inc
$ 0.1436
(-60.22%)
33.25M
CMCTCreative Media and Community Trust Corporation
$ 0.790799
(-49.47%)
2.36M
SFIXStitch Fix Inc
$ 2.37
(-36.80%)
12.36M
BNZIBanzai International Inc
$ 5.5916
(-32.14%)
2.41M
SHOTWSafety Shot Inc
$ 0.22
(-31.25%)
11.2k
NVDANVIDIA Corporation
$ 123.4199
(2.11%)
184.37M
CEROCERo Therapeutics Holdings Inc
$ 0.1011
(7.90%)
110.74M
MLGOMicroAlgo Inc
$ 0.2568
(18.78%)
100.65M
OCTOEightco Holdings Inc
$ 3.7588
(50.96%)
93.15M
SQQQProShares UltraPro Short QQQ
$ 7.4818
(-2.20%)
83.02M

ACLX Discussion

View Posts
Monksdream Monksdream 1 week ago
ACLX new 52 week high
👍️0
Monksdream Monksdream 2 months ago
ACLX under $100
👍️0
Monksdream Monksdream 6 months ago
ACLX over $30
👍️0
Monksdream Monksdream 8 months ago
ACLX new 52 week high
👍️0
Monksdream Monksdream 8 months ago
ACLX new 52 week high
👍️0
Monksdream Monksdream 8 months ago
ACLX new 52 week high
👍️0
bandit007 bandit007 2 years ago
Going beast mode into next week.
👍️0
TheyWantYourShares TheyWantYourShares 2 years ago
Nice correction coming here. New IPO at 16… company is flush with capital/cash. Moves coming and getting in now will pay off big IMHO.


Got in on the drop @average: 13.12 … 2 and 3 days ago.


$ACLX


GLTA!!



-TWYS
👍️0
crudeoil24 crudeoil24 3 years ago
Net loss of $44M > no revenues! ( over 9 month period)

ACLX
👍️0
crudeoil24 crudeoil24 3 years ago
Arcellx Inc. ACLX, has set terms for its initial public offering, in which the Maryland-based biotechnology company, which is developing cancer treatments, looks to raise up to $140.25 million. The company said it is offering 8.25 million shares in the IPO, which is expected to price between $15 and $17 a share. With 33.54 million shares expected to be outstanding after the IPO, the expected pricing could value the company at up to $570.24 million. The stock is expected to list on the Nasdaq under the ticker symbol "ACLX." BofA Securities, SVB Leerink, Barclays and William Blair are the lead underwriters. The company recorded a net loss of $44.30 million on no revenue during the nine months ended Sept. 30, after a loss of $23.00 million on no revenue in the same period a year ago. Arcellx is looking to go public at a time of relative investor disdain for IPOs and biotechs, as the Renaissance IPO ETF IPO, -3.27% has plunged 37.2% over the past three months and the iShares Biotechnology ETF IBB, -1.39% has tumbled 19.8%, while the S&P 500 SPX, +0.31% has slipped 3.8%.
👍️0

Your Recent History

Delayed Upgrade Clock